This inventor holds 3 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: Hsiu-Ching Chang: Innovator in Recombinant DNA Technology
Introduction
Hsiu-Ching Chang is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. With a total of 3 patents to her name, her work has had a profound impact on medical research and therapeutic applications.
Latest Patents
Among her latest patents is the invention titled "Recombinant DNA-produced T11 and fragments thereof." This patent describes a cDNA sequence encoding human T11 or a fragment thereof, which is capable of inhibiting T-lymphocyte activation. This innovation holds potential for advancing treatments in immunology and cancer therapy.
Career Highlights
Hsiu-Ching Chang is currently affiliated with the Dana-Farber Cancer Institute Inc., where she continues her research and development efforts. Her work at this esteemed institution has allowed her to collaborate with leading experts in the field and contribute to groundbreaking discoveries.
Collaborations
Some of her notable coworkers include Neil Richardson and Ellis L. Reinherz. These collaborations have further enriched her research and expanded the scope of her innovations.
Conclusion
Hsiu-Ching Chang's contributions to recombinant DNA technology exemplify the vital role of inventors in advancing scientific knowledge and medical treatments. Her work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile